Page 40 - 77_01

NANOTECNOLOGÍA
FARMACÉUTICA…..

74. Ghosn, B., Singh, A. & Roy, K. (2008) Efficient siRNA delivery by secondary and tertiary
amine modified polysaccharides. NSTI-Nanotech. 2: 338-341.

75. Lee, D. W., Yun, K.-S., Ban, H.-S., Choe, W., Lee, S. K. & Lee, K. Y. (2009) Preparation and
characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. J. Control
Release. 139: 146-152.

76. Jere, D., Jiang, H.-L., Kim, Y.-K., Arote, R., Choi, Y.-J., Yun, C.-H., Cho, M.-H. & Cho, C.-S.:
(2009) Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. Int. J.
Pharm. 378: 194-200.

77. Jiang, H.-L., Xu, C.-X., Kim, Y.-K., Arote, R., Jere, D., Lim, H.-T., Cho, M.-H. & Cho, C.-S.
(2009) The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-
polyethylenimine/Akt1 siRNA complexes through the Akt signaling pathway. Biomaterials.
30: 5844-5852.

78. Rudzinski, W. E. & Aminabhavi, T. M. (2010) Chitosan as a carrier for targeted delivery of
small interfering RNA. International J. Phar. 399: 1-11.

79. Minakuchi, Y., Takeshita, F., Kosaka, N., Sasaki, H., Yamamoto, Y., Kouno, M., Honma, K.,
Nagahara, S., Hanai, K., Sano, A., Kato, T. I., Terada, T. M. & Ochiyal, O. (2004)
Atelocollagen-mediated synthetic small interferingRNA delivery for effective gene silencing in
vitro and in vivo. Nucleic Acids Research. 132: 13 e109.

80. Mu, P., Nagahara, S., Makita, M., Tarumi, Y., Kadomatsu, K. & Takei, Y. (2010) Systemic
delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using
siRNA targeting Bcl-xL and cisplatin against prostate cancer. Int. J. Cancer. 25(12): 2978-90.

81. Forootan, S. S., Bao, Z. Z., Forootan, F. S., Kamalian, L., Zhang, Y., Bee, A., Foster, C. S. &
Ke, Y. (2010) Atelocollagen-delivered siRNA targeting the FABP5 gene as an experimental
therapy for prostate cancer in mouse xenografts. Int. J. Oncol. 36(1): 69-76.

82. Dutta, T., Narendra, N. K., Nigel, A. J. McMillan, A. J. & Parekh, H. S. (2010) Nanomedicine.
Nanotechnology, Biology, and Medicine. 6: 460-470.

83. Dutta, T., Agashe, H. B., Vijayarajkumar, P., Joshi, M. & Jain, N. K. (2006) Dendrosome based
gene delivery. J. Exp. Nanoscience. 1: 235-248.

84. Gao, H. & Hui, K. M. (2001) Novel series of cationic lipids that can act as efficient gene
delivery vehicles through systematic heterocyclic substitution of cholesterol derivatives. Gene
Ther. 8: 855-863.

85. de Fougerolles, A. R. (2008) Delivery vehicles for small interfering siRNA in vivo. Human Gen.
Ther. 19: 125-132.

86. Weisman, S., Hirsch-Lerner, D., Barenholz Y. & Talmon, Y. (2004) Nanostruture of cationic
lipid-oligonucleotide complexes. Biophys. J. 87: 609-614.

87. Radler, J. O., Koltover, I., Saldin, T. & Safinya, C. R. (1997) Structure of DNA-cationic
liposomes complexes: DNA intercalation in multilamellar membranes in distinct interhelical
packing regimes. Science. 275: 810-814.

88. Lu, J. J., Langer, R. & Chen J. (2009) A novel mechanism is involved in cationic lipid-mediated
functional siRNA delivery. Mol. Pharm. 6: 763-771.

89. Xu, Y. & Szoka, F. C. (1996) Mechanism of DNA release from cationic liposome/DNA
complexes issued in cell transfection. Biochemistry. 35: 5616-5623.

90. Reddy, J. A. & Low, P. S. (2000) Enhanced folate receptor mediated gene therapy using a novel
pH-sensitive lipid formulation. J. Control Release. 64: 27-37.

91. Fretz, M. M., Mastrobattista, E, Koning, G. A., Jiskoot, W. & Storm, G. (2005) Strategies for
cytosolic delivery of liposomal macromolecules. Int. J. Pharm. 298: 305-309.

92. Dokka, S., Toledo, D., Shi, X., Castranova, V. & Rojanasakul, Y. (2000) Oxygen radical-
mediated pulmonary toxicity induced by some cationic liposomes. Pharm. Res. 17: 521.

93. Lv, H., Zhang, S., Wang, B., Cui, S. & Yan, J. (2006) Toxicity of cationic lipids and cationic
polymers in gene delivery. J. Control Release. 114: 100-109.

94. Ren, T., Song, Y. K., Zhang, G. & Liu, D. (2000) Structural basis of DOTMA for its high
intravenous transfection activity in mouse. Gene Ther. 7: 764-768.

95. Han, S. E., Kang, H. & Shim, G. Y. (2008) Novel cationic colesterol derivative-based liposomes
for serum-enhanced delivery of siRNA. Int. J. Pharm. 353: 260-269.

96. Wolfrum, C., Shi, S., Jayaprakash, K. N. et al. (2007) Mechanisms and optimization of in vivo

delivery of lipophilic siRNAs. Nat. Biotechnol. 25: 1149-1157.
97. Ozpolat, B., Sood, A.K. & Lopez-Berensteinm G. (2009) Nanomedicine based approaches for

the delivery of siRNA in cancer. J. Int Med. 267: 44-53.
98. Gewirtz, A. M. (2007) On future’s doorstep: RNA interference and the pharmacopeia of

tomorrow. J. Clin. Invest. 17: 3612-3614.

49